Latest Market Research Updates

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

The global mHealth apps market size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 44.7% during the forecast period. The market is majorly driven by increasing adoption of advanced technologies in healthcare facilities and the need to reduce long waiting periods to access healthcare facilities from specialists.Availability of mobile applications for users is witnessing a rapid growth, especially healthcare apps that assist consumers in self-management of disease, wellness, and chronic conditions. This increased role of patients coupled with the rising importance in staying updated and informed about their own healthcare decisions, contributing to the rise in adoption of mHealth apps globally.

Healthcare industry has been transitioning towards a value-based care model with mHealth becoming a widespread trend owing to the advent of technologies such as remote monitoring, electronic medical record, and other communication platforms. The increasing prevalence of disorders, such as diabetes, hypertension, cancer, and obesity along with the growing awareness about wellness and other preventive measures diseases among patients is expected to boost the mHealth market growth.

mHealth leverages from the 4Ps: personalized, predictive, participatory, and preventive measures for care delivery to provide optimal care to users. Moreover, rising penetration of smartphones, and other electronic devices, especially, in low- and middle-income countries and increasing focus on the use of mobile technology to manage care delivery is anticipated to benefit the market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/mhealth-app-market

Further key findings from the report suggest:

Rapid growth in chronic diseases along with the rise in the number of app users is accountable for the mHealth apps market growth
The types of mHealth apps include fitness, lifestyle management, nutrition and diet, women’s health, medication adherence, healthcare providers, and disease management. Of these, the fitness category accounted for the majority of segment share in 2018
mHealth app vendors are focusing their attention on women's health, diet, and medication reminders. According to Wired, a mobile advertising and analytics platform, women are more inclined toward tracking their health than men
Physicians are increasingly recommending the use of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps
North America led the mhealth applications market in 2018 in terms of revenue share pertaining to the technological advancements and presence of major players in the region
Some of the key players are Johnson & Johnson; Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd; Novartis AG; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer; and Sanofi

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Bone Grafts and Substitutes Market Is Projected To Reach $3.9 Billion By 2025

The global bone grafts and substitutes market size is expected to reach USD 3.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to register a healthy CAGR of 5.5% during the forecast period. Demand for bone grafts and substitutes is increasing due to adoption of newer technologies and increasing demand for minimally invasive procedures.

Availability of advanced products in varied shapes and sizes providing high osteoconductive and osteoinductive properties is supporting market growth. Moreover, growing adoption of minimally invasive procedures is spurring demand for bone grafts and substitutes. In minimally invasive procedures, large incisions and damage to muscles surrounding repair area can be significantly avoided. These techniques also reduce the duration of hospital stay and support rapid wound healing with lesser pain and surgical wounds. Minimally invasive total joint replacement and spine surgeries are some of the newly adopted procedures. Some of the companies in the bone grafts and substitutes market are DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/bone-grafts-substitutes-market

Further key findings from the study suggest:

Increasing number of orthopedic surgeries and rising demand for minimally invasive surgeries are primary factors driving market growth
By material type, allografts accounted for the largest market share within the natural segment in 2016, mainly due to properties such as immediate structural support and osteoconductivity. Moreover, allografts do not require another surgery to harvest the bone, which results in reduced surgery time and wound healing, thus, attributing toward segment growth
North America is the leading regional market, followed by Europe. Rising awareness regarding commercially available products, higher healthcare expenditure, and availability of advanced healthcare infrastructure are prime factors responsible for the region’s expansion
Key players in the market include DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

About Grand View Research

Healthcare Staffing Market Is Projected To Reach $44.65 Billion By 2025

The global healthcare staffing market size is likely to reach USD 44.65 billion by 2025, based on a new report by Grand View Research, Inc., exhibiting a CAGR of 5.0% during the forecast period. Rising geriatric population is stirring up the demand for healthcare services around the globe. However, there is a shortage of efficient nurses and other healthcare professionals.

Shortage of physicians in developed regions is expected to bolster the growth of the healthcare staffing market. For instance, the Association of American Medical Colleges had predicted in 2010 that the U.S. is estimated to face a shortage of 150,000 doctors over the next 10 to 15 years. Furthermore, availability of skilled professionals at lower costs as and when required is anticipated to propel the market in the coming years.

Also, in response to pressure of costs, hospitals are forced to reduce their staff and have implemented policies to ensure that nurses would be available for work when workload increases. The healthcare staffing market has significant penetration and can easily provide staff during emergencies.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-staffing-market

Further key findings from the study suggest:

The allied healthcare segment accounted for the largest revenue share in the market in 2018. It includes physical therapists, medical technologists, occupational therapists, respiratory therapists, pharmacists, and phlebotomists
The locum tenens segment is projected to witness the fastest growth during the forecast period. This can be attributed to cost-effectiveness for employers and increase in the number of physicians choosing to work as locum tenens
North America will lead the market through 2025 due to increasing geriatric population, lack of skilled professionals as compared to demand, and local presence of several market players
Asia Pacific is likely to experience the fastest growth during the next decade due to increasing investments by several market players, positive economic outlook, and rising awareness about contract staffing
Some of the key players are Envision Healthcare Corporation; AMN Healthcare; CHG Management, Inc.; Maxim Healthcare Services, Inc.; Cross Country Healthcare, Inc.; inVentiv Health; Almost Family; TeamHealth; and Adecco Group.

About Grand View Research

Population Health Management Market Is Poised To Reach $101.0 Billion By 2025

The global population health management market size is expected to reach USD 101.0 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 20.7% during the forecast period. The need for population health services that combine multiple functionalities is increasing, due to the complex nature of care delivery and payment models. PHM solutions can process clinical, financial, and operational data for the improvement of efficiency and patient care. The convenience offered by value-based payment models instead of Fee-for-Service (FFS) is responsible for increased adoption of these solutions by the Accountable Care Organizations (ACOs).

ACOs, consist of hospitals, clinics, doctors, and other caregivers, collaborate with payers for the delivery of high-quality patient care. Private and public insurance providers have introduced various disease management programs, to assist in the treatment of chronic illnesses. These multidisciplinary efforts are expected to result in effective treatment outcomes and are likely to suggest best suitable courses of action that need to be undertaken. Successful large-scale trials in U.S. have enabled significant advancements in disease management programs.

The market has a healthy mix of vendors offering PHM along with other healthcare IT solutions. Acquisitions and partnerships are the major strategies adopted by the companies operating in the population health management market. For instance, in 2018 Allscripts announced completion of acquisition of the HealthGrid Holding Company, a developer of enterprise patient engagement solution. The acquisition signifies expansion of the Allscripts FollowMyHealth platform that provides patient engagement solutions focused on connecting consumers with providers.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/population-health-management-phm-market

Further key findings from the report suggest:

Based on the products, the services segment held majority of the market share in 2018, as healthcare providers prefer in-house maintenance services
In 2018, healthcare provider held the largest market share of the end-use segment. The providers can focus effectively on patient-centric care and reducing overall costs
North America was the largest regional market in 2018 and is likely to retain its position over the forecast period, as the providers, payers, providers-payers, and accountable care organizations promote the use of PHM services
Asia Pacific is expected to witness the fastest growth in the forthcoming years due to rising healthcare expenditure and improving healthcare infrastructure
Allscripts, McKesson Corporation, and Cerner Corporation among others are some of the key players operating in the Population Health Management (PHM) market. Business partnerships and acquisitions are some of the key strategic initiatives undertaken by these companies to strengthen their market presence.

About Grand View Research

Home Infusion Therapy Market Is Projected To Reach $38.7 Billion By 2026

The global home infusion therapy market size is expected to reach USD 38.7 billion by 2026 registering a CAGR of 7.2% from 2019 to 2026, according to a new report by Grand View Research, Inc. Rapid technological advancements are some major factors contributing to the market growth. Home infusion is gradually being considered as an alternative to extended stay in hospitals or nursing homes for patients suffering from chronic diseases. With the administration of medications in home settings, patients recover faster, are more comfortable, and save money. Several government and non-government programs aimed at reducing the burden of hospital stays by establishing infusion centers that provide quick IV infusion services are likely to have a positive impact on the market.

Furthermore, favorable government policies and regulations are expected to propel the industry growth. In addition, rising prevalence of diseases, such as Cardiovascular Diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to be a high impact rendering driver for the market. According to the WHO, at present, all the aforementioned diseases account for 60% of total deaths and 43% of the disease burden in U.S. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids, which in turn, is expected to boost the market growth in the region.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

Further key findings from the study suggest:

Infusion pumps led the product segment in 2018 owing to their extensive use for the delivery of fluids, such as medications and nutrients, during infusion therapy
Needleless connectors is the fastest-growing product segment over the forecast period. These devices provide protection from needlestick injuries
Anti-infective segment held the largest share in 2018 owing to a large number of procedures performed for administering antibiotics and antifungals
The chemotherapy segment is expected to witness lucrative growth during the forecast period on account of initiatives undertaken pertaining to cancer treatment, such as development of infusion centers by the Cancer Treatment Centers of America
The market is highly competitive and is marked by the presence of key companies, such as B. Braun Melsungen AG; ICU Medical, Inc.; Baxter; Fresenius Kabi AG; Caesarea Medical Electronics; Terumo Corporation; CareFusion Corporation; JMS Co. Ltd.; and Smiths Medical
Most of these companies focus on new product development to maintain their position in the global home infusion therapy market

About Grand View Research

Biosensors Market Is Projected To Reach $33.76 Billion By 2026

The global biosensors market size is anticipated to reach USD 33.76 billion by 2026 registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Various applications in the medical field, high demand for miniature diagnostic devices, and rapid technological advancements are the key driving factors for biosensors market growth. Early and precise disease diagnosis is essential for successful prognosis of diseases and survival of patients. In recent years, the demand for simple, disposable, user-friendly, and cost-efficient devices with fast response time has increased extensively leading to increase in the sales of these products, thereby driving the market.

Continuous technological developments are also expected to boost the market. For instance, in October 2015, Abbott Laboratories launched FreeStyle Libre Glucose Monitoring System in Europe. It is intended to be a replacement for blood glucose meters. Moreover, rising applications of thermal biosensors in biomolecular interaction and hybridization analysis, environmental monitoring, and cosmetic analysis are expected to boost the biosensors market growth. In addition, the development of nano particle-based electrochemical biosensors is expected to create growth opportunities for the key comapnies, thereby driving the market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/biosensors-market

Further key findings from the study suggest:

Medical application segment led the market in 2018. Medical wearable biosensors are considered an essential tool in the detection and monitoring of a wide range of medical conditions, such as diabetes and cancer
Electrochemical biosensors accounted for the largest market share in 2018 and are anticipated to witness a significant growth over the forecast period
This growth can be attributed to its widespread applications for quantification and analysis in biochemical and biological processes
On the basis of end use, biosensors in food industry are expected to witness a rapid growth owing to rising pressure from regulatory bodies pertaining to the hygiene standards of the food items where this device plays a vital role for detecting pathogens, allergens, and pesticides
Asia Pacific market is expected to witness the fastest growth over the forecast period owing to increasing awareness regarding wearable biosensors and constantly improving healthcare facilities in the region
Key companies in the market includes AZUR Environmental; Abbott Laboratories; Biosensor BV; Bayer AG; Cranfield Biotechnology Centre; DuPont Biosensor Materials; Ercon, Inc.; and Johnson & Johnson

About Grand View Research

Neurorehabilitation Devices Market Is Projected To Reach $3.2 Billion By 2024

The global neurorehabilitation devices market in 2015 was valued at USD 915.1 million and is estimated to reach USD 3.2 billion by 2024. Around 1 billion people are suffering from neurological disorders across the globe. These neurological disorders are resulting in increased movement disabilities. The increasing prevalence of movement disability, attributed to various neurological disorders (multiple sclerosis, stroke, etc) along with need for comprehensive management is the key factors driving the market growth.

Every year around 15 million people suffer from stroke globally, of which 5 million people are affected by permanent disability. Each year Multiple sclerosis and Parkinson’s disease affect 2.5 million and 10 million patients respectively worldwide. The increasing prevalence and incidence rates of neurological disorders create a huge demand for neurorehab devices, as they ensure simplification of routine tasks for the disabled patients by reducing their dependency on others.

Furthermore, the rising awareness of neurorehab services among the care providers is contributing to the increasing adoption of these devices. In addition, consistent technological advancements are leading to introduction and commercialization of novel products in this sector. Majority of the manufacturers and distributors of neurorehab platforms are headquartered in North America region. North America dominates the market followed by Europe attributed to the rising awareness and increased adoption of novel technologies in these regions. Asia Pacific is growing at the highest CAGR among all the regions due to increasing target population and improving healthcare infrastructure.

Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy. Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players. For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/neurorehabilitation-devices-market

Further Key Findings from the Study Suggest:

Neurorobotics is expected to be one of the most lucrative segments in the coming years owing to the high availability of exoskeletons and prosthetics targeted for treating movement disabilities. Bioness, Inc. and Hocoma AG are few of the key manufacturers of exoskeletons and prosthetics.
Consistent technological sophistications in brain stimulations and machine learning brain-computer interface segment is expected to develop tremendously.
Non invasive stimulators have the potential to modulate brain plasticity. In February 2016, USFDA approved Medtronic’s brain stimulation therapy in the treatment of Parkinson’s disease.

About Grand View Research

Latest Market Research Updates

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

Bone Grafts and Substitutes Market Is Projected To Reach $3.9 Billion By 2025

Healthcare Staffing Market Is Projected To Reach $44.65 Billion By 2025

Population Health Management Market Is Poised To Reach $101.0 Billion By 2025

Home Infusion Therapy Market Is Projected To Reach $38.7 Billion By 2026

Biosensors Market Is Projected To Reach $33.76 Billion By 2026

Neurorehabilitation Devices Market Is Projected To Reach $3.2 Billion By 2024

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

Report Abuse

Labels